Coffee Extracts Suppress Tryptophan Breakdown in Mitogen-Stimulated Peripheral Blood Mononuclear Cells

REFERENCES

• Higdon JV, Frei B: Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101–123, 2006.
   PubMed Web of Science ®Google Scholar
• Food Standards Agency: Food survey information sheet. Survey of caffeine levels in hot beverages. 2004. Accessed at: http://www.food.gov.uk/science/surveillance
   Google Scholar
• Blanchard J, Sawers SJ: The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24:93–98, 1983.
   PubMed Web of Science ®Google Scholar
• Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 37:693–703, 1997.
   PubMed Web of Science ®Google Scholar
• Alvi SN, Hammami MM: Validated HPLC method for determination of caffeine level in human plasma using synthetic plasma: application to bioavailability studies. J Chromatogr Sci 49:292–296, 2011.
   PubMed Web of Science ®Google Scholar
• Judelson DA, Preston AG, Miller DL, Muñoz CX, Kellogg MD, Lieberman HR: Effects of theobromine and caffeine on mood and vigilance. J Clin Psychopharmacol 33:499–506, 2013.
   PubMed Web of Science ®Google Scholar
• Thelander G, Jönsson AK, Personne M, Forsberg GS, Lundqvist KM, Ahlner J: Caffeine fatalities—do sales restrictions prevent intentional intoxications? Clin Toxicol (Phila) 48:354–358, 2010.
   PubMed Web of Science ®Google Scholar
• Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A: Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 16:R136, 2012.
   Google Scholar
• Borrell B: Plant biotechnology: make it a decaf. Nature 483:264–266, 2012.
   Google Scholar
• Clifford MN: Chlorogenic acids and other cinnamates—nature, occurrence and dietary burden. J Sci Food Agric 79:362–372, 1999.
   Web of Science ®Google Scholar
• Wang Y, Ho CT: Polyphenolic chemistry of tea and coffee: a century of progress. J Agric Food Chem 57:8109–8114, 2009.
   PubMed Web of Science ®Google Scholar
• Farah A, Monteiro M, Donangelo CM, Lafay S: Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 138:2309–2315, 2008.
   PubMed Web of Science ®Google Scholar
• Stalmach A, Mullen W, Barron D, Uchida K, Yokota T, Cavin C, Steiling H, Williamson G, Crozier A: Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos 37:1749–1758, 2009.
   PubMed Web of Science ®Google Scholar
• Renouf M, Guy PA, Marmet C, Fraering AL, Longet K, Moulin J, Enslen M, Barron D, Dionisi F, Cavin C, Williamson G, Steiling H: Measurement of caffeic and ferulic acid equivalents in plasma after coffee consumption: small intestine and colon are key sites for coffee metabolism. Mol Nutr Food Res 54:760–766, 2010.
   PubMed Web of Science ®Google Scholar
• Monteiro M, Farah A, Perrone D, Trugo LC, Donangelo C: Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 137:2196–2201, 2007.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen M, Ju W, Liu S, Xu M, Chu J, Wu T: Liquid chromatograph/tandem mass spectrometry assay for the simultaneous determination of chlorogenic acid and cinnamic acid in plasma and its application to a pharmacokinetic study. J Pharm Biomed Anal 51:685–690, 2010.
   PubMed Web of Science ®Google Scholar
• Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I: Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 131:1207–1210, 2001.
   PubMed Web of Science ®Google Scholar
• Natella F, Nardini M, Belelli F, Pignatelli P, Di Santo S, Ghiselli A, Violi F, Scaccini C: Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br J Nutr 100:1276–1282, 2008.
   PubMed Web of Science ®Google Scholar
• Tuñón MJ, García-Mediavilla MV, Sánchez-Campos S, González-Gallego J: Potential of flavonoids as anti-inflammatory agents: modulation of pro-inflammatory gene expression and signal transduction pathways. Curr Drug Metab 10:256–271, 2009.
   PubMed Web of Science ®Google Scholar
• Ritter M, Hohenberger K, Alter P, Herzum M, Tebbe J, Maisch M: Caffeine inhibits cytokine expression in lymphocytes. Cytokine 30:177–181, 2005.
   PubMed Web of Science ®Google Scholar
• Richelle M, Tavazzi I, Offord E: Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem 49:3438–3442, 2001.
   Google Scholar
• Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs DR Jr, Ose L, Blomhoff R: Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134:562–567, 2004.
   PubMed Web of Science ®Google Scholar
• Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H: Immune response–associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp Med 160:310–316, 1984.
   PubMed Web of Science ®Google Scholar
• Murr C, Widner B, Wirleitner B, Fuchs D: Neopterin as a marker for immune system activation. Curr Drug Metab 3:175–187, 2002.
   PubMed Web of Science ®Google Scholar
• Fuchs D, Moeller AA, Reibnegger G, Stockle E, Werner ER, Wachter H: Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 3:873–876, 1990.
   PubMed Web of Science ®Google Scholar
• Pfefferkorn ER: Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 81:908–912, 1984.
   PubMed Web of Science ®Google Scholar
• Ozaki Y, Edelstein MP, Duch DS: Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. Proc Natl Acad Sci USA 85:1242–1246, 1988.
   PubMed Web of Science ®Google Scholar
• Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363–1372, 1999.
   PubMed Web of Science ®Google Scholar
• Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA: Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596–3599, 2000.
   PubMed Web of Science ®Google Scholar
• Schroecksnadel K, Wirleitner B, Winkler C, Fuchs D: Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364:82–90, 2006.
   PubMed Web of Science ®Google Scholar
• Jenny M, Klieber M, Zaknun D, Schroecksnadel S, Kurz K, Ledochowski M, Schennach H, Fuchs D: In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm Res 60:127–135, 2010.
   PubMed Web of Science ®Google Scholar
• Widner B, Werner ER, Schennach H, Wachter H, Fuchs D: Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424–2426, 1997.
   PubMed Web of Science ®Google Scholar
• Ou B, Hampsch-Woodill M, Prior RL: Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 49:4619–4626, 2001.
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55, 1984.
   PubMedGoogle Scholar
• Thomas SR, Terentis AC, Cai H, Takikawa O, Levina A, Lay PA, Freewan M, Stocker R: Post–translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem., 282:23778–23787, 2007.
   PubMed Web of Science ®Google Scholar
• Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H: Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler 370:1063–1069, 1989.
   PubMed Web of Science ®Google Scholar
• Bruce C, Yates DH, Thomas PS: Caffeine decreases exhaled nitric oxide. Thorax 57:361–363, 2002.
   PubMed Web of Science ®Google Scholar
• Barone JJ, Roberts HR: Caffeine consumption. Food Chem Toxicol 34:119–129, 1996.
   PubMed Web of Science ®Google Scholar
• Spiller MA: The chemical components of coffee. Prog Clin Biol Res 158:91–147, 1984.
   PubMedGoogle Scholar
• Gómez-Ruiz JA, Leake DS, Ames JM: In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 55:6962–6969, 2007.
   PubMed Web of Science ®Google Scholar
• Valadão Vicente SJ, Ishimoto EY, Cruz RJ, Seabra Pereira CD, Torres EA: Increase of the activity of phase II antioxidant enzymes in rats after a single dose of coffee. J Agric Food Chem 59:10887–10892, 2011.
   PubMed Web of Science ®Google Scholar
• Krakauer T: The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol Immunotoxicol 24:113–119, 2002.
   PubMed Web of Science ®Google Scholar
• Feng R, Lu Y, Bowman LL, Qian Y, Castranova V, Ding M: Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280:27888–27895, 2005.
   PubMed Web of Science ®Google Scholar
• Schroecksnadel S, Jenny M, Kurz K, Klein A, Ledochowski M, Ueberall F, Fuchs D: LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem Biophys Res Comm 399:642–646, 2010.
   PubMed Web of Science ®Google Scholar
• Kim JY, Jung KS, Lee KJ, Na HK, Chun HK, Kho YH, Jeong HG: The coffee diterpene kahweol suppress the inducible nitric oxide synthase expression in macrophages. Cancer Lett 213:147–154, 2004.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Shin HS, Satsu H, Totsuka M, Shimizu M: 5-Caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-alpha-induced secretion of interleukin-8 from Caco-2 cells. J Agric Food Chem 56:3863–3868, 2008.
   PubMed Web of Science ®Google Scholar
• Horrigan LA, Kelly JP, Connor TJ: Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 111:877–892, 2006.
   PubMed Web of Science ®Google Scholar
• Bessler H, Salman H, Bergman M, Djaldetti M: On the factors modulating the effect of statins on malignant cell proliferation. Cancer Invest 25:279–284, 2007.
   PubMed Web of Science ®Google Scholar
• Ulcar R, Schuligoi R, Heinemann A, Santner B, Amann R: Inhibition of prostaglandin biosynthesis in human endotoxin-stimulated peripheral blood monocytes: effects of caffeine. Pharmacology 67:67–71, 2003.
   PubMed Web of Science ®Google Scholar
• Rosenthal LA, Taub DD, Moors MA, Blank KJ: Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes. Immunopharmacology 24:203–217, 1992.
   PubMed Web of Science ®Google Scholar
• Perera V, Gross AS, Xu H, McLachlan AJ: Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics. J Pharm Pharmacol 63:1161–1168, 2011.
   PubMed Web of Science ®Google Scholar
• Cuvelier ME, Richard H, Berset C: Comparison of the antioxidant activity of some acid phenols—structure activity relationship. Biosci Biotechnol Biochem 56:324–325, 1992.
   Web of Science ®Google Scholar
• Chen JH, Ho CT: Antioxidant activities of caffeic acid and its related hydroxycinnamic acid compounds. J Agric. Food Chem 45:2374–2378, 1997.
   Web of Science ®Google Scholar
• Moon MK, Lee YJ, Kim JS, Kang DG, Lee HS: Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. Biol Pharm Bull 32:1371–1377, 2009.
   PubMed Web of Science ®Google Scholar
• Ferk F, Chakraborty A, Jäger W, Kundi M, Bichler J, Mišík M, Wagner KH, Grasl-Kraupp B, Sagmeister S, Haidinger G, Hoelzl C, Nersesyan A, Dušinská M, Simić T, Knasmüller S: Potent protection of gallic acid against DNA oxidation: results of human and animal experiments. Mutat Res 715:61–71, 2011.
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Vacca C, Orabona C, Spreca A, Fioretti MC, Puccetti P: T cell apoptosis by kynurenines. Adv Exp Med Biol 527:183–190, 2003.
   PubMed Web of Science ®Google Scholar
• Becker K, Schroecksnadel S, Gostner J, Zaknun C, Schennach H, Uberall F, Fuchs D: Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds. Phytomedicine 21:164–171, 2014.
   PubMed Web of Science ®Google Scholar
• Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C: Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 80:862–867, 2004.
   PubMed Web of Science ®Google Scholar
• Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R: Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 83:1039–1046, 2006.
   PubMed Web of Science ®Google Scholar
• Montagnana M, Favaloro EJ, Lippi G: Coffee intake and cardiovascular disease: virtue does not take center stage. Semin Thromb Hemost 38:164–177, 2012.
   PubMed Web of Science ®Google Scholar
• Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D: Neopterin production tryptophan degradation and mental depression: what is the link? Brain Behav Immun 16:590–595, 2002.
   PubMed Web of Science ®Google Scholar
• Capuron L, Dantzer R: Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17:119–124, 2003.
   Google Scholar
• Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D: Tryptophan degradation and immune activation in Alzheimer's disease. J Neural Transm 107:343–353, 2000.
   PubMed Web of Science ®Google Scholar
• Widner B, Leblhuber F, Fuchs D: Increased neopterin production and tryptophan degradation in advanced Parkinson's disease. J Neural Transm 109:181–189, 2002.
   PubMed Web of Science ®Google Scholar
• Barranco Quintana JL, Allam MF, Serrano Del Castillo A, Fernández-Crehuet Navajas R: Alzheimer's disease and coffee: a quantitative review. Neurol Res 29:91–95, 2007.
   PubMed Web of Science ®Google Scholar
• Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J: Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 22:2242–2248, 2007.
   PubMed Web of Science ®Google Scholar
• Kawachi I, Willett WC, Colditz GA, Stampfer MJ, Speizer FE: A prospective study of coffee drinking and suicide in women. Arch Intern Med 156:521–525, 1996.
   PubMed Web of Science ®Google Scholar
• Tanskanen A, Tuomilehto J, Viinamaki H, Vartiainen E, Lehtonen J, Puska P: Heavy coffee drinking and the risk of suicide. Eur J Epidemiol 16:789–791, 2000.
   PubMed Web of Science ®Google Scholar
• Gershon MD, Tack J: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132:397–414, 2007.
   PubMed Web of Science ®Google Scholar
• Received January 29, 2014; revision accepted March 20, 2014.
   Google Scholar